Background: Inflammatory bowel disease (IBD) is associated with an inappropriate immune response to the gut microbiota. Notably, patients with IBD reportedly have alterations in fecal microbiota. However, the colonic microbiota occupies both the gut lumen and the mucus covering the epithelium. Thus, information about mucus-resident microbiota fails to be conveyed in the routine microbiota analyses of stool samples. Further, studies analyzing microbiota in IBD have mainly focused on stool samples taken after onset of inflammation. Our objective was to investigate both temporal and spatial changes in colonic microbiota communities preceding the onset of colitis.
T he gastrointestinal tract microbiota is a complex and diverse microbial ecosystem. 1 The gastrointestinal tract microbiota performs essential functions for host physiology such as nutrient metabolism, inhibition of pathogen colonization, and education and development of the immune system. 2, 3 Despite the beneficial aspects of the microbiota, its abundance and proximity to the host poses a continuous challenge for the mucosal immune system. Therefore, the immune system has evolved mechanisms to tolerate the gut microbiota 2, 4 and anatomically contain it in the lumen and the outer mucus layer to maintain homeostasis. 5 A dense inner mucus layer that is considered sterile and is enriched in antimicrobial products mediates physical segregation of microbes from the intestinal epithelium. 6, 7 Inflammatory bowel disease (IBD), comprising Crohn's disease and ulcerative colitis (UC), is thought to result from dysregulated immune responses to the microbiota 8, 9 and has been associated with decreased bacterial diversity (particularly the Firmicutes phylum) and an altered balance of residential microbiota, so-called dysbiosis. [10] [11] [12] Dysbiosis in IBD is varied and includes structural changes in the gut microbiota and impairments in microbial metabolic function. 13 Compositional or functional dysbiosis might compromise immune homeostasis, resulting in excessive inflammation against gut microbiota and vice versa, immune dysfunction might drive shifts in microbial structure establishing dysbiosis. 11, 14 Studies in individuals with IBD have examined the gut microbiota composition either during disease onset but before treatment 15 or after establishment of disease and clinical management. [16] [17] [18] [19] [20] [21] Furthermore, most human studies have focused on stool samples, which do not fully replicate the Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.ibdjournal.org).
complexity of the microbiota communities in situ. 16, 19, 21 Bacterial composition differs depending on the niche that microbiota inhabit, for example, the small intestine versus the large intestine or mucus layer overlying the epithelium versus the gut lumen. 22 Stool samples cannot capture these differences and it may be that more subtle changes in microbial communities undetected in stool are evident in specific niches in the gut before inflammation. We sought to address the composition and location of microbiota over time focusing on time points before the onset of any detectable inflammation and at onset of inflammation. Many mouse models of IBD rely on altering the immune system (either by impairing it or activating it), or adding chemical or infectious agents that drive UC. Although the models have provided valuable information, they may not be the most appropriate models to understand the local changes in bacteria over time, as changes may be attributed to the trigger and not the environment. For this reason, we used the mdr1a 2/2 spontaneous model of UC, which has an intact immune system, 23 and littermate controls to control for the environment. Our data revealed that changes in mucus but not stool bacteria preceded the onset of inflammation and highlight the importance of sampling the mucus to better understand disease mechanisms.
MATERIALS AND METHODS

Maintenance of Animals
Mdr1a 2/2 mice (FVB.129P2-Abcb1atm1Bor N7) 24 and control FVB mice purchased from Taconic Farms (Albany, NY) were crossbred to generate F2 littermates and maintained under specific, pathogen-free conditions at the University of Manchester. Cohoused littermate mdr1a 2/2 and wild-type (WT) males were used throughout to ensure shared microbiota. All experimental procedures in mice were performed in accordance with the regulations issued by the Home Office under amended ASPA, 2012. The incidence of colitis in the mdr1a 2/2 colony maintained at Manchester at 18 weeks of age was 18%.
Isolation of Bacterial Genomic DNA
Stool samples were collected and frozen immediately in dry ice. Colon tissue was opened up longitudinally and washed in sterile phosphate-buffered saline to remove luminal contents. Mucus was scraped for the collection of mucus-resident bacteria. DNA extraction from stool and mucus samples was performed using the QIAamp DNA Stool Mini Kit (Qiagen, Manchester, United Kingdom).
Denaturing Gradient Gel Electrophoresis Analysis
Eubacterial 16S rRNA genes were amplified using the universal primer pairs P3_GC-341F and P2_518R (see Table S1 , Supplemental Digital Content 1, http://links.lww.com/IBD/B496), purified using the MinElute PCR Purification kit (Qiagen) and loaded onto a denaturing gradient gel electrophoresis gel with a 30%-70% denaturing gradient. Gel images were analyzed using BioNumerics software (Applied Maths, TX). A similarity matrix between sample fingerprints was extracted and principal component analysis was performed using MATLAB (MathWorks, MA). Nonmetric multidimensional scaling using Bray-Curtis dissimilarity distances and statistical analysis (PERMANOVA; adonis function) was performed using the vegan package in R (http:// cran.r-project.org).
Quantification of Bacterial Load and GramPositive/Gram-Negative Bacteria Numbers
Bacterial abundance in feces and mucus layer was measured by quantitative polymerase chain reaction (qPCR), using eubacterial 16S rRNA gene primers (forward 5 0 -ACTCCTACGG-GAGGCAGCAGT-3 0 , reverse 5 0 -ATTACCGCGGCTGCTGGC-3 0 ) and the Power SYBR Green Master Mix (Applied Biosystems, supplied by Fischer Scientific, Loughborough, United Kingdom) as previously described. 7 Gram-positive and Gram-negative bacteria numbers were quantified using Taqman Gene Expression Master Mix (Applied Biosystems) with specific probes (see Table S1 , Supplemental Digital Content 1, http://links.lww.com/ IBD/B496) as previously reported. 25 Bacterial abundances were determined using standard curves constructed by a Topo-TA vector plasmid containing a cloned region (179 bp) of the 16S rRNA gene. Bacterial measurements in stool and mucus samples were normalized to the initial amount of each sample. Bacterial measurements correspond to the number of gene copies and not actual bacterial numbers or colony forming units.
Relative Quantitative Analysis of Clostridiales
The relative quantity of Clostridiales in mucus and stools was assessed using the primers UniF338 5 0 -ACTCCTACGG-GAGGCAGC-3 0 and C.cocR491 5 0 -GCTTCTTAGTCAGG-TACCGTCAT-3 0 and the Power SYBR Green Master Mix (Applied Biosystems) as previously described. 26 Universal 16S rRNA gene primers (forward 5 0 -ACTCCTACGGGAGGCAG-CAGT-3 0 , reverse 5 0 -ATTACCGCGGCTGCTGGC-3 0 ) were used for normalization to the total amount of bacteria. Results were calculated by the 2 2DDCt method and were also normalized to the dilution and initial weight of the sample.
16S rRNA Gene Sequencing Analysis
16S amplicon sequencing targeting the V3 and V4 variable regions of the 16S rRNA (see Table S1 , Supplemental Digital Content 1, http://links.lww.com/IBD/B496) was performed on the Illumina MiSeq platform according to manufacturer's guidelines and generated paired-end reads of 300 bp in each direction. Illumina reads were initially demultiplexed to remove adapter sequences and trim primers. Then, Illumina paired-end reads were merged together using SeqPrep (http://github.com/jstjohn/SeqPrep) and submitted to EMBL-EBI's metagenomics pipeline. 27 Reads were preprocessed to remove low quality and uninformative reads before further analysis steps in the QIIME pipeline v.1.9.0. 28 The quality-filtering process included removal of reads with low quality ends (i.e. ambiguous leading/trailing bases), removal of reads where the proportion of ambiguous bases is higher than 10%, and removal of reads with length less than 300 bp. Sequences corresponding to rRNA were selected using a filter for prokaryotic rRNA reads and were clustered to operational taxonomic units (OTUs) using a closed-reference OTU picking strategy in QIIME based on UCLST. 29 OTU representative sequences were then taxonomically classified using the Greengenes reference database (version 13.8) filtered at 97% identity. 30, 31 A resulting OTU table was generated giving the OTU abundances in each sample with taxonomic identification for each OTU. A mean sequence depth of 244,484 sequences per sample was obtained.
Sequences were also processed using the vsearch analysis pipeline (https://github.com/torognes/vsearch) to perform a more stringent quality control filtering based on the removal of chimeras. Demultiplexed sequences derived from Illumina pipeline initial processing were joined together and annotated to their respective sample ids. Sequences were then quality filtered using the value 19 as phred quality threshold in QIIME 32 and further processed in vsearch pipeline. A mean sequence depth of 249,971 sequences per sample was obtained. Analysis via the EBI and vsearch pipeline concurred.
Alpha-and beta-diversity measures were calculated with QIIME 28 and principal coordinate analysis plots were produced based on weighted UniFrac distance. 33, 34 Alpha-diversities were compared using compare_alpha_diversity.py and beta diversities were compared using adonis in compare_categories.py. To examine complex microbial communities with many confounding variables, multivariate statistical analysis was applied by regressing the relative abundance of each bacterial taxon on each one of the sample variables. Multivariate association with linear models (MaAsLin) analysis is a pipeline that uses multivariate association tests to identify significant associations of bacterial taxa with a specific sample variable without the confounding effect of other sample variables. MaAsLin was performed using default parameters (http://huttenhower.sph.harvard.edu/maaslin). 13 Sample id was used as a random effect and the following variables (genotype, age, location, colitis, litter, housing, and total reads) were used to identify association with the abundance of each taxon. Phylum abundance data were used to build a model to predict sample location (i.e., mucus or stool) and it can be found in the link: file:///Users/maria/Downloads/metagenome. html. All P-values were corrected for multiple hypothesis testing using the Benjamini-Hochberg false discovery rate method, 35 and significant association was considered below a false discovery rate q-value threshold of 0.05.
Histology and Colitis Score
Distal colon sections were stained with hematoxylin and eosin (H&E) for histological assessment of tissue integrity and with alcian blue dye for goblet cell visualization. For enumeration of crypt lengths and goblet cells, the average number from a minimum of 60 crypts/slide from at least 3 slides was calculated per mouse. Slide pictures were taken using the slide scanner (Pannoramic 250 Flash), and analyzed using Panoramic Viewer software (3DHISTECH) and ImageJ (http://rsb.info.nih.gov/ij). All tissue was blinded before analysis. The sum of scores for crypt length elongation (score 0-4), goblet cell depletion (score 0-4), muscle wall thickness (score 0-4), inflammatory cell infiltration (score 0-4), and destruction of architecture (score 0 or 3-4) was calculated (maximum 20) (see Table S2 , Supplemental Digital Content 1, http://links.lww.com/IBD/B496).
Real-Time Reverse Transcriptase-PCR
RNA extraction from proximal colon tissue samples was performed using TRIsure (Bioline, London, United Kingdom) in accordance with the manufacturer's instructions. Two microgram of RNA was treated with RNase-free DNase (Promega, Southampton, United Kingdom) and converted to cDNA using oligo(dT)18 primers and the BioScript reverse transcriptase (Bioline). Real-time Reverse Transcriptase-PCR was performed using the Power SYBR Green Master Mix (Applied Biosystems) on a StepOnePlus Realtime PCR system (Thermo Fisher Scientific, Paisley, United Kingdom). Each reaction contained 1x Power SYBR Green Master Mix, 300 nM of each primer pair, 1 mL template and nuclease-free water made up to 20 mL. The following cycling conditions were used: 10 minutes at 958C for 1 cycle, and 40 cycles of 15 seconds at 958C, and 1 minute at 608C. Gene expression values were normalized based on GAPDH expression for each sample. The following primer pairs were used: IFN-g, forward 5
0 -GCGTCATTGAATCA-CACCTG-3 0 , reverse 5 0 -ACCTGTGGGTTGTTGACCTC-3 0 , and
Fluorescence In Situ Hybridization (FISH) and Mucin MUC2 Immunostaining
Distal colon tissue was fixed in methanol-Carnoy's solution to preserve mucus integrity. 5 FISH staining was performed using the universal bacterial probe-EUB338 (5 0 -Cy3-GCTGCCTCCCGTAGGAGT-3 0 ), followed by immunostaining with a rabbit polyclonal MUC2 antibody and goat anti-rabbit Alexa-Fluor 488 antibody (Life technologies, Paisley, United Kingdom). A nonspecific probe directed at fungus Cryptococcus was used as a control (5 0 -Cy3-CCAGCCCTTATCCACCGA-3 0 ). Sections were mounted in ProLong antifade mounting medium containing 4',6-diamidino-2-phenylindole (DAPI) (Life technologies) and analyzed using ImageJ. A minimum of 3 different distal colon sections was used for each sample. The thickness of the inner mucus layer was quantified by measuring the distance between epithelium and the start of outer mucus layer. Mucus penetration by bacteria was also evaluated. Gut location score was assigned values ranging from 0 to 4, thus: 0 ¼ bacteria in the lumen and outer mucus layer; 1 ¼ bacteria in the inner mucus layer; 2 ¼ bacteria in contact with the epithelium; 3 ¼ bacteria in the crypts and 4 ¼ bacteria in the lamina propria. A score of 5 to 6 would indicate mild to moderate inflammation when compared with normal mice which had a score of 0 to 1. All slides were scored blinded.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6 (GraphPad software, CA). Normally distributed data were analyzed by one-way analysis of variance with Tukey's posttest or unpaired t test as appropriate to the number of comparisons being made. Data that did not exhibit a normal distribution were analyzed using the nonparametric Kruskal-Wallis test with Dunn's posttest or Mann-Whitney test. Correlation analysis was performed using the Pearson correlation coefficient. P , 0.05 was considered as statistically significant (*P , 0.05, **P , 0.01, ***P , 0.001, ****P , 0.0001).
RESULTS
Microbiota is Altered in the Mucus Before the Onset of Inflammation
We monitored colitis progression in mdr1a 2/2 mice from 4 weeks to 25 weeks (see Fig. S1A , Supplemental Digital Content 1, http://links.lww.com/IBD/B496) and observed a slow progression of disease incidence in agreement with previous reports in mdr1a 2/2 mice reared under specific, pathogen-free conditions. 36, 37 We selected an early time point at 6 weeks to represent a disease-free postweaning state and a later time point, at 18 weeks, when signs of inflammation begin to appear (Fig.  1A) . Histological examination of 6-week-old mdr1a 2/2 and WT mice revealed normal gut morphology with no signs of inflammation (see Fig. S1B , Supplemental Digital Content 1, http:// links.lww.com/IBD/B496), in agreement with previous findings from our group based on gene expression analysis. 36 By 18 weeks however, a subset of mdr1a 2/2 mice exhibited histological evidence of inflammation characteristic of progression to active disease (see Fig. S1C , Supplemental Digital Content 1, http://links.lww.com/IBD/B496). By 25 weeks most of the older mdr1a 2/2 mice had very inflamed guts with either moderate to severe disease (see Fig. S1A , Supplemental Digital Content 1, http://links.lww.com/IBD/B496). Mdr1a 2/2 mice had similar crypt length, muscle wall thickness, and goblet cell numbers relative to their WT counterparts at both time points with the exception of those 18-week-old mice with indications of colitis (see Figs. S1D-S1G, Supplemental Digital Content 1, http:// links.lww.com/IBD/B496). To further characterize whether there were molecular indicators of inflammation detectable before onset of histological inflammation we performed qPCR for the inflammatory cytokine IFN-g. Expression of IFN-g was absent in WT and mdr1a 2/2 mice at 6 weeks and in 18-week-old WT mice; however, its levels were increased in the subset of mdr1a 2/2 mice at 18 weeks of age that also showed indication of histological inflammation (see Fig. S1H , Supplemental Digital Content 1, http://links.lww.com/IBD/B496).
To identify changes in microbiota composition that could promote a disturbed microbiota-epithelium crosstalk, we investigated the microbial consortium in both stools and mucus. Principal component analysis of microbial fingerprints showed a shift in the overall community composition between young WT and mdr1a 2/2 mice that was limited to the mucus at 6 weeks (Fig. 1B) . In contrast, the microbial profiles in stool samples were very similar, indicating that changes in microbial composition start locally at specific niches. Nonmetric multidimensional scaling analysis of these data using Bray-Curtis distances also revealed a diversification of mucus microbial communities between control and mdr1a 2/2 mice at 6 weeks (PERMANOVA: R2 ¼ 0.128, P , 0.05 for mucus; no difference in group variance).
We examined whether the altered microbial profile is associated with overall differences in the balance of Grampositive and Gram-negative bacteria. Many pathobionts that belong to Gram-negative bacteria such as Enterobacteriaceae have increased abundance in IBD stool samples. 10 We found similar numbers of Gram-positive and Gram-negative bacteria between WT and knockout mice in the mucus and stools at 6 weeks (Fig. 1C, see Fig. S2A , Supplemental Digital Content 1, http://links.lww.com/IBD/B496); although mucus Grampositive bacteria were more variable (F test of variance, P , 0.05). The numbers of Gram-positive bacteria present in the stools were significantly higher than Gram-negative bacteria in both WT and knockout mice (P , 0.001) (see Fig. S2A , Supplemental Digital Content 1, http://links.lww.com/IBD/ B496).
Despite the different mucus microbial profile at 6 weeks, the total bacterial load, as assessed by qPCR of total 16S rRNA gene copy number, remained the same between young WT and mdr1a 2/2 animals at that site (Fig. 1D) . We also observed no significant difference in stool bacterial loads (see Fig. S2B , Supplemental Digital Content 1, http://links.lww.com/IBD/B496). Therefore, bacterial numbers were equivalent in the mucus, but the taxonomic composition of bacterial communities was different (see Fig. S1E , Supplemental Digital Content 1, http:// links.lww.com/IBD/B496). Interestingly, the relative abundance of Clostridiales, which has previously been associated with the maintenance of tolerance to the microbiota 38 tended to be increased in WT controls, whereas the S24-7 family, part of Bacteroidetes phylum, exhibited reduced levels; this microbial pattern observed in the mucus was not reproduced in the stool samples (see Fig. S2C , Supplemental Digital Content 1, http:// links.lww.com/IBD/B496). In agreement with 16S Illumina sequencing data, qPCR analysis of Clostridiales revealed similar abundance between WT and mdr1a 2/2 mice in the stools at 6 weeks of age. In contrast, the relative abundance of Clostridiales in the mucus tended to be reduced in the mdr1a 2/2 mice at 6 weeks of age compared with age-matched WT mice (see Fig.  S2D , Supplemental Digital Content 1, http://links.lww.com/ IBD/B496). Microbial diversity was not affected by genotype either in mucus or faeces (see Fig. S2E , Supplemental Digital Content 1, http://links.lww.com/IBD/B496).
Principal coordinate analysis of the weighted UniFrac distance showed distinct clustering of mucus and fecal microbial assemblies (see Fig. S3A , Supplemental Digital Content 1, http:// links.lww.com/IBD/B496) as shown in previous reports. 13, 15, 22 16S rRNA gene survey analysis also revealed differences in microbial composition (see Fig. S3B , Supplemental Digital Content 1, http://links.lww.com/IBD/B496) and diversity (see Fig. S3C , Supplemental Digital Content 1, http://links.lww.com/ IBD/B496). Firmicutes were more abundant in the mucus, whereas Bacteroidetes dominated the stool (see Fig. S3B , Supplemental Digital Content 1, http://links.lww.com/IBD/ B496). The levels of those 2 phyla could distinguish sampling location using a predictor model in Python: (file:///Users/maria/ Downloads/metagenome.html). FIGURE 1. Differences in mdr1a 2/2 microbiota composition in the mucus are evident before onset of inflammation. Stool and mucus microbiota were analyzed by Illumina sequencing from WT and mdr1a 2/2 mice at 6 weeks. A, Histopathology scoring of distal colon tissue samples obtained from 6 and 18-week WT and mdr1a 2/2 mice (n ¼ 11-16). B, Principal component analysis plot of fingerprinting data of fecal and mucus-associated microbiota from WT and mdr1a 2/2 mice (n ¼ 7-8/group), showing differential clustering of mucus microbiota from WT and mdr1a 2/2 mice but no clear clustering in stool bacteria (PERMANOVA; P , 0.05 for mucus and nonsignificant for stool). C, Balance of Gram-positive and Gramnegative bacteria in mucus microbial communities. n ¼ 10 mice per genotype. D, Bacterial load from the mucus was quantified by 16S rRNA gene copy number. n ¼ 5 mice per genotype; data are from 3 littermate groups. E, Summary of the relative abundance of mucus microbiota at the family level (n ¼ 5/group). In case sequences could not be taxonomically assigned to the family level, the closest relative was given. Clostridiales corresponds to order level. The category "others" represents bacterial families with abundance below 0.1%. Data shown as mean 6 SD. *P , 0.05 by Kruskal-Wallis test with Dunn's multiple comparisons test (A), 1-way analysis of variance with Tukey's multiple comparisons test (C) and Mann-Whitney test (D).
Microbiota Differences Start in the Mucus and Progress to the Stools over Time, Concordant with the Onset of Inflammation
Our data revealed changes in the mucus bacteria before any indicators of inflammation at 6 weeks. We hypothesized that such changes in microbiota composition start in the mucus and are later evident in the stools. Indeed, a differential clustering of global microbial profiles between 18-week-old WT and mdr1a 2/2 mice exhibiting indicators of inflammation was evident in both the mucus and stool (Fig. 2A) . Nonmetric multidimensional scaling analysis of these data using Bray-Curtis distances also revealed separation of mucus microbial communities between control and mdr1a 2/2 mice (PERMANOVA: R2 ¼ 0.293, P ¼ 0.015 for mucus and R2 ¼ 0.192, P ¼ 0.021 for stools; no difference in group variance).
The abundance of Gram-positive bacteria was much higher only in mdr1a 2/2 mice compared with the levels of Gramnegative bacteria in the mucus at 18 weeks (Fig. 2B) . On the contrary, levels of Gram-positive bacteria in the stools were increased in both WT and mdr1a 2/2 mice compared with Gram-negative bacteria levels (see Fig. S4A , Supplemental Digital Content 1, http://links.lww.com/IBD/B496). Notably mdr1a 2/2 mice exhibiting signs of inflammation showed a significant increase in the numbers of Gram-negative bacteria in the stools (P , 0.05, see 2C ). Thus, there was an association between mdr1a 2/2 mice that presented with a higher colitis score and elevated levels of Gram-negative bacteria.
Overall 18-week-old mdr1a 2/2 mice harbored similar numbers of mucus and stool bacteria ( Fig. 2D and see Fig.  S4C , Supplemental Digital Content 1, http://links.lww.com/ IBD/B496). Nonetheless, they showed an altered abundance of bacterial groups (see Figs. S2E and S4D, Supplemental Digital Content 1, http://links.lww.com/IBD/B496). Members of the mucus microbial communities that belong to Bacteroides and the mucus-degrading Akkermansia tended to be increased in 18-week-old mdr1a 2/2 mice. We also noted increased Clostridiales in older mdr1a 2/2 mice. qPCR was used to confirm whether there was an increased load of Clostridiales in the mucus of 18-week-old mdr1a 2/2 mice. Although Clostridiales were similar in stool samples from WT and 18-week-old mdr1a 2/2 mice, in agreement with our sequencing data there was a significant increase (P ¼ 0.0312) in Clostridiales in older mdr1a 2/2 mice (see Fig. S2D , Supplemental Digital Content 1, http://links.lww.com/IBD/B496). Mdr1a 2/2 mice that exhibited severe inflammation had a distinctive microbial profile compared with healthy age-matched knockout mice (Fig. 3A, Figs. S4D and S5, Supplemental Digital Content 1, http://links.lww.com/IBD/B496). There was evidence that the microbial profiles of the mucus and stools were more similar to each other in mice showing overt inflammation than those with little or no inflammation.
To gain insight into the effect of mdr1a gene deficiency into driving inflammation, we looked at the microbial composition in WT and mdr1a 2/2 mice. Interestingly, compared with WT, mdr1a 2/2 mice showed similar alpha diversity both in their mucus and stools (Fig. 3B, C) . To determine a correlation between the gut microbial composition and status of disease, we used the multivariate association with linear models (MaAsLin) analysis. 13 Progression to colitis associated with an increase in the abundance of S24-7 (Fig. 3D) , whereas Clostridiales tended to decline in frequency (Fig. 3E) . MaAsLin analysis further revealed differences in the abundance for different taxonomic groups such as Betaproteobacteria between WT and mdr1a 2/2 mice (see Fig.  S6 , Supplemental Digital Content 1, http://links.lww.com/IBD/ B496). Our data suggest that specific bacterial taxa are altered in the mucus in colitis-prone animals before disease onset and that these differences are later also apparent in the stools after inflammation has developed.
Altered Location of Microbiota in ColitisProne Mice
To identify whether microbial localization is implicated in an altered host-bacterial relationship, we examined the spatial distribution of microbiota in the context of colitis development by FISH using a universal 16S rRNA gene probe (see Fig.  S7A -S7C, Supplemental Digital Content 1, http://links.lww. com/IBD/B496). We observed that bacteria were mostly located at the outer mucus layer in 6-week-old WT and mdr1a 2/2 mice; however, few bacteria were occasionally found in the inner mucus layer (Fig. 4A, B) . The spatial separation between microbiota and intestinal mucosa was maintained in 18-week WT mice. In contrast, microbiota was frequently observed to have penetrated the inner mucus barrier and contacted the intestinal epithelial surface in age-matched cohoused mdr1a 2/2 mice (P , 0.01, Fig. 4A, C) . In cases of severe inflammation, bacteria also colonized the intestinal crypts and penetrated the lamina propria.
Immunostaining of MUC2 revealed that the thickness of the inner mucus was decreased in mdr1a 2/2 mice compared with age-matched controls at 6 weeks (P , 0.05, Fig. 4D ). Moreover, as mdr1a 2/2 mice aged (18 weeks), the mucus layer diminished significantly (P , 0.05, Fig. 4E ). Our findings reveal an association between bacterial penetration, as evidenced in higher gut location score, and the grade of inflammation (r ¼ 0.86, r 2 ¼ 0.73, P , 0.01, Fig. 4F) . A reduction in mucus thickness was negatively correlated with the grade of inflammation (r ¼ 20.754, r 2 ¼ 0.569, P , 0.05, Fig. 4G ). The decrease in mucus layer may provide the opportunity for colonization by commensal bacteria that are normally excluded from direct epithelial contact. These results suggest that the spatial relationship between microbiota and host intestinal tissue is disrupted before the onset of colitis symptoms, creating a hypersensitive environment that challenges the immune system.
DISCUSSION
The composition of the gut microbiota is known to be disturbed in chronic intestinal inflammatory conditions. 10, 11, 14 Here, we show that compositional changes in the mucus microbiota can be detected long before the onset of inflammation (12 weeks before inflammation was evident) in colitis-prone mice. Despite the fact that the total bacterial load was similar, mdr1a 2/2 animals had reduced proportions of Clostridiales and higher abundance of S24-7 group in their mucus communities. Clostridiales have been associated with the development of Tregs, [38] [39] [40] and it has been reported that mdr1a 2/2 animals have reduced frequency of Foxp3 + Tregs in the lamina propria. 41 Therefore, the reduction in mucus Clostridiales in mdr1a 2/2 animals could have altered the mucus-microbiota/immune-dialog and as a result impaired the induction of Tregs. Moreover, reduction in the abundance of Clostridiales is associated with progression to colitis. Interestingly, a previous study that correlated high Immunoglobulin A (IgA) binding of bacteria with colitogenic potential FIGURE 3. Disrupted bacterial relationships in mdr1a 2/2 animals progressing to disease. A, Principal component analysis plot of stool and mucus samples based on fingerprinting data from WT and mdr1a 2/2 mice at 18 weeks (n ¼ 4-6/group) showing differential clustering of stool microbial communities in mdr1a 2/2 animals with no inflammation compared with age-matched mdr1a 2/2 with inflammation. B, Alpha diversity rarefaction plots of phylogenetic diversity in WT and mdr1a 2/2 mice in mucus and (C) stools at 18 weeks (n ¼ 5/group, mean 6 SD). D and E, Significant community shifts were associated with progression to inflammation in mdr1a 2/2 mice compared with healthy WT and disease-free mdr1a 2/2 mice. Analysis and associated false discovery rate-corrected P values were computed using MaAsLin. FIGURE 4. Altered gut microbial location and mucus thickness precede inflammation in colitis-prone mdr1a 2/2 mice. A, Representative images of microbiota localization in distal colon tissue by FISH at 2 time points, 6 and 18 weeks. Bacteria were stained with the universal eubacterial 16S rRNA gene probe-EUB338 (red) and mucus was identified with an anti-MUC2 specific antiserum (green). Tissue was counterstained with DAPI (blue). Dotted lines indicate the inner mucus layer (I) that separates the intestinal epithelium (e) from the outer mucus layer (O). Arrowheads point to bacteria in the inner mucus layer and in contact with the epithelium. Sections are representative of .8 littermate groups. Scale bars ¼ 20 mm. B, Scoring of bacterial location in distal colon tissue samples derived from 6-and (C) 18-week-old WT and mdr1a 2/2 mice (n ¼ 8-10). D, Thickness of the inner mucus layer in WT and mdr1a 2/2 mice at 6 weeks and (E) 18 weeks. F, Correlation of bacterial location scoring and (G) inner mucus thickness with disease status in mdr1a 2/2 mice at 18 weeks. A higher colitis score was associated with decreased mucus thickness and increased bacterial penetrance. Data shown are mean 6 SEM. *P , 0.05; **P , 0.01 as determined by unpaired t test in (B) and (D), unpaired t test with Welch's correction in (E) and Mann-Whitney test (C). P , 0.01 in (F) and P , 0.05 in (G) by Pearson correlation analysis.
implicated the S24-7 as commensal bacteria with high IgA coating. 42 Thus, early changes in microbiota may be favoring an environment that is more colitogenic and less tolerogenic.
In accordance with our findings, a previous study 43 showed differences in the caecal microbiota of mdr1a 2/2 animals compared with controls at around 12 weeks of age. Inflammation was not assessed in this study, but rather inferred to be absent based on an earlier study from the same group 37 ; however, it is important to state that other groups have reported that 12 weeks is associated with active inflammation. 36, 44 Changes such as expression of interferon response genes, levels of inflammation, and disease onset can be variable in the mdr1a 2/2 model, thus it is critical to understand what the level of inflammation or inflammatory markers are in the same mice the microbiota is analyzed. 36 Importantly, our study identifies changes in colon mucus bacteria at a very early time point when there is no evidence of either histological inflammation or expression of any molecular indicators of inflammation. In addition, it is important to control for the environment in microbiota studies, as there is substantial microbial variation between cages, location, and litters 45 ; we have achieved this by using littermate controls in cohousing conditions.
Spatial segregation of microbiota is crucial for the maintenance of homeostasis. 6 Mdr1a 2/2 animals had a thinner inner mucus barrier at an early age indicating a compromised mucus barrier before the emergence of any indicators of inflammation. A marked reduction of the mucus thickness was evident during the development of inflammation in agreement with previous reports on active inflammation in murine UC models 46 or IBD patients. 47, 48 Notwithstanding, spatial segregation of microbiota was maintained in mdr1a 2/2 mice at a young age (i.e., 6 weeks) as previously described. 36 Bacteria have been shown to penetrate the inner mucus layer and reach the epithelium in murine models of colitis and patients with active UC. 49 Akin to this work, breach of the mucus barrier in mdr1a 2/2 animals was most frequently observed during the onset of inflammation. Indeed, mdr1a 2/2 mice with a higher penetration of invading bacteria also had worsened gut pathology. Bacteria initially colonized the epithelium and in severe inflammation invaded the host tissue. Previous studies also suggested a correlation between severity of inflammation and bacterial penetration in the inner colonic mucus, 46 ,49 but our study shows reduced mucus barrier thickness and thus altered mucus properties before disease onset. Recent findings indicate that bacteria themselves can influence mucus barrier properties 50 and because mucus bacterial composition is altered in mdr1a 2/2 mice before disease, and before the mucus barrier properties are lost, it may contribute to that impaired mucus barrier and subsequently to inflammatory pathology.
The shift in microbial community composition that was initially identified in the mucus of colitis-prone mice progresses to stools over time, concurrently with the development of inflammation. The abundance of Gram-negative bacteria was elevated in the stools of colitis-prone animals and showed a positive correlation with the severity of inflammation. The increase in Gram-negative bacteria is a sign of microbial imbalance. 11, 51 We found that the levels of Bacteroides, Akkermansia, and Clostridiales increased on disease onset in the intestinal mucus in mdr1a 2/2 mice. The increase in Clostridiales in mdr1a 2/2 mice at 18 weeks of age could be an attempt to counterbalance inflammation. Akkermansia sp. are mucin-degrading bacteria residing in mucus. 52 Studies in human UC samples from tissue biopsies and feces have shown reduced numbers of Akkermansia sp.; 12, 53 however, these studies report an increase in other mucolytic bacteria. 54 The increase in Akkermansia abundance together with an increased proportion of Bacteroides, which produce mucusdegrading sulfatases, 54 suggests an excess of liberated mucus glycans, facilitating the expansion of harmful bacteria that forage on these readily provided glycans. The differences in communities at 6 and 18 weeks reveal the importance of sampling over time to better unpick potential drivers and initiators of inflammation and/or homeostasis. The distinct microbial pattern we observed differentiated not only disease-prone animals from healthy controls, but also disease-prone animals exhibiting varying grades of colitis. Severe inflammation was associated with a different microbial profile compared with low-grade inflammation.
Overall, our data indicate that differences in microbiota composition start in the mucus before the onset of inflammation and then later extend to stools in parallel with an altered mucus barrier. On disease onset, loss of spatial compartmentalization of bacteria could further trigger the immune system and fuel the inflammatory cascade and vice versa. Our findings provide a framework for understanding the temporal and spatial variation of microbial communities in the context of IBD and highlight the importance of sampling mucus-associated microbiota.
